A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
about
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study Osimertinib in Patient ...... r With Uncommon EGFR Mutations
@en
type
label
A Study Osimertinib in Patient ...... r With Uncommon EGFR Mutations
@en
prefLabel
A Study Osimertinib in Patient ...... r With Uncommon EGFR Mutations
@en
P1476
A Single Arm Phase II Study Os ...... r With Uncommon EGFR Mutations
@en
P3098
NCT03434418
P4844
P580
2018-06-30T00:00:00Z
P582
2021-06-30T00:00:00Z